- Home
- OLP vs ARCT Comparison
OLP vs ARCT Comparison
Compare OLP & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLP
- ARCT
- Stock Information
- Founded
- OLP 1982
- ARCT 2013
- Country
- OLP United States
- ARCT United States
- Employees
- OLP N/A
- ARCT N/A
- Industry
- OLP Real Estate Investment Trusts
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- OLP Real Estate
- ARCT Health Care
- Exchange
- OLP Nasdaq
- ARCT Nasdaq
- Market Cap
- OLP N/A
- ARCT 487.0M
- IPO Year
- OLP N/A
- ARCT N/A
- Fundamental
- Price
- OLP $25.52
- ARCT $17.12
- Analyst Decision
- OLP Strong Buy
- ARCT Strong Buy
- Analyst Count
- OLP 1
- ARCT 7
- Target Price
- OLP $28.00
- ARCT $65.00
- AVG Volume (30 Days)
- OLP 51.6K
- ARCT 356.8K
- Earning Date
- OLP 03-04-2025
- ARCT 03-06-2025
- Dividend Yield
- OLP 7.05%
- ARCT N/A
- EPS Growth
- OLP 51.11
- ARCT N/A
- EPS
- OLP 1.63
- ARCT N/A
- Revenue
- OLP $89,142,000.00
- ARCT $160,399,000.00
- Revenue This Year
- OLP N/A
- ARCT $7.33
- Revenue Next Year
- OLP $4.71
- ARCT $4.71
- P/E Ratio
- OLP $15.66
- ARCT N/A
- Revenue Growth
- OLP N/A
- ARCT N/A
- 52 Week Low
- OLP $19.25
- ARCT $14.30
- 52 Week High
- OLP $30.45
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- OLP 37.95
- ARCT 48.75
- Support Level
- OLP $25.08
- ARCT $15.82
- Resistance Level
- OLP $26.25
- ARCT $17.93
- Average True Range (ATR)
- OLP 0.58
- ARCT 1.51
- MACD
- OLP 0.02
- ARCT -0.04
- Stochastic Oscillator
- OLP 27.89
- ARCT 23.90
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.